Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. [electronic resource]
Producer: 20081112Description: 387-93 p. digitalISSN:- 1365-2133
- Adult
- Aged
- Aged, 80 and over
- Aminolevulinic Acid -- therapeutic use
- Carcinoma, Basal Cell -- drug therapy
- Dose-Response Relationship, Drug
- Female
- Humans
- Iron Chelating Agents -- adverse effects
- Male
- Middle Aged
- Pain -- etiology
- Photochemotherapy -- adverse effects
- Photosensitizing Agents -- therapeutic use
- Pilot Projects
- Pyridones -- adverse effects
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.